A Breathalyzer for Disease
Our Mission: To save 100,000 lives and $1.5B in healthcare costs.
Our Vision: Become the global leader in non‑invasive diagnostics for cancer, infectious disease & inflammatory disease.
Breath Biopsy - VOC Biomarkers in Breath
A non-invasive way to access a patient’s metabolome, for early detection and real time monitoring of disease activityLearn about breath biopsy
Our Research Products
Bring VOC biomarker research to your own lab with our complete range of R&D instrumentsOur research products
Our Research Services
VOC biomarker discovery and validation research services with our world class team and facilitiesOur research services
Introducing the FAIMS microchip, revolutionary science at the nanoscale
At Owlstone Medical we have developed a chemical sensor on a silicon chip 100x cheaper and 1000x smaller than existing technologies: the FAIMS microchip.
Lonestar VOC Analyzer
A non-invasive, easy to use analyzer for the detection of disease biomarkers in clinical samples
ReCIVA Breath Sampler
A reliable and reproducible way to capture VOC biomarkers in breath samples
Biomarker Services tailored to your needs and clinical objectives
Volatile organic compound (VOC) biomarker discovery and validation for early detection, therapeutic response, drug toxicity and disease monitoring for cancer, inflammatory, and infectious diseases.
Taking action to permanently change non-invasive medical diagnostics through innovative clinical projects
We have an active clinical diagnostics pipeline across oncology and inflammatory diseases.
Owlstone Medical and Cancer Research UK (CRUK) Initiate Pan Cancer Clinical Trial to Evaluate Breath Biopsy for Early Detection of Disease
Owlstone Medical CEO and Breath Biopsy Pioneer Billy Boyle wins Royal Academy of Engineering’s Silver Medal